$3.000
-0.097 (-3.23%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
INTS Prediction & Forecast by Similar Chart Analysis
Alphio's INTS stock price prediction model matches the current Intensity Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.02 (+0.53%). The 1-week path is $3.21 (+7.13%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Intensity Therapeutics Inc Stock?
Intensity Therapeutics Inc is not a good buy right now due to its significant financial losses and negative momentum. The stock has a current price of $3.00, a 52-week low of $2.80, and has declined 70.52% year-to-date. Additionally, the RSI is at 28.195, indicating oversold conditions but also a lack of bullish momentum. The most pressing risk is the company's widening losses, with a reported net loss of $3 million for Q2 2026, which raises concerns about its financial sustainability and operational capacity.
INTS stock price ended at $3.00 on Friday, after losing -3.23%
Intensity Therapeutics Inc (INTS) last closed at $3, losing -3.23%. These facts feed the 1-day and 1-week INTS price prediction above.
Forecast Drivers
Intensity Therapeutics Inc (INTS) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches INTS, ranked by similarity.
Seasonality analysis for INTS
Historically the probability of a positive November return for INTS is 0.00%. January offers the highest probability of a positive month at 42.62%, while May is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for INTS
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Nov 2026 | $0.32 | $0.33 | $0.39 | -88.91% |
| Dec 2026 | $0.32 | $0.38 | $0.42 | -87.39% |
In 2026, Intensity Therapeutics Inc (INTS) is projected to range from $0.32 to $0.42.
Intensity Therapeutics Inc 2026 monthly forecast
In Nov 2026, Intensity Therapeutics Inc is projected to average $0.33, with a low of $0.32 and high of $0.39.
In Dec 2026, Intensity Therapeutics Inc is projected to average $0.38, with a low of $0.32 and high of $0.42.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.